Ozagrel

Ozagrel
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid;
CAS Number	82571-53-7 ;
PubChem CID	5282440;
ChemSpider	4445594 ;
UNII	L256JB984D;
KEGG	D08327 ;
ChEMBL	ChEMBL11662 ;
CompTox Dashboard (EPA)	DTXSID6048547 ;
ECHA InfoCard	100.122.039
Chemical and physical data
Formula	C13H12N2O2
Molar mass	228.251 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O;
	InChI InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+ ; Key:SHZKQBHERIJWAO-AATRIKPKSA-N ;
	(what is this?) (verify)

Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.^[1]

References

↑ Loo MH, Egan D, Vaughan ED, Marion D, Felsen D, Weisman S (March 1987). "The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction". J. Urol. 137 (3): 571–6. doi:10.1016/s0022-5347(17)44108-5. PMID 3820396.

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.